Avoid common mistakes on your manuscript.
Correction to: Cancer Chemotherapy and Pharmacology (2020) 85:585–592 https://doi.org/10.1007/s00280-019-04020-z
The authors wish to report two errors in the formulae in Table 1 concerning the formulae used to estimate creatinine clearance.
In the BSA adjusted CKD-EPI formula (Calvert-CKD-EPI) [1], the formula for eGFR should read.
Calvert CKD-EPI | pCL (mL/min) = eGFR + 25 eGFR = 141 × min(cre/κ1, 1)α1 × max(cre/κ1, 1) −1.209 × 0.993Age [× 1.018 if female] × (BSA/1.73) κ1 is 0.7 for females and 0.9 for males, α1 is − 0.329 for females and − 0.411 for males, min is the minimum of cre/κ1 or 1, and max is the maximum of cer/κ1 or 1 |
Similarly, in the BSA adjusted CKD-EPI creatinine-cystatin equation (Calvert-CKD-EPI_cys) [2] the formula for eGFR should read.
Calvert CKD-EPI-cysC | pCL (mL/min) = eGFR + 25 eGFR = 135 × min(cre/κ2, 1)α2 × max(cre/κ2, 1) −0.601 × min(CysC/0.8, 1)−0.375 × max(CysC/0.8, 1) −0.711 × 0.995Age [× 0.969 if female] × (BSA/1.73) κ2 is 0.7 for females and 0.9 for males, α2 is − 0.248 for females and − 0.207 for males, min indicates the minimum of cre/κ2 or 1, and max indicates the maximum of cre/κ2 or 1 |
References
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29. https://doi.org/10.1056/NEJMoa1114248
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
White-Koning, M., Paludetto, M.N., Le Louedec, F. et al. Correction to: Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance. Cancer Chemother Pharmacol 88, 171 (2021). https://doi.org/10.1007/s00280-021-04268-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-021-04268-4